Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cetylpyridinium chloride anhydrous

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with cetylpyridinium chloride anhydrous in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(cetylpyridinium chloride anhydrous)
Trials
(cetylpyridinium chloride anhydrous)
Recent Studies (post-2010) (cetylpyridinium chloride anhydrous)
9,15618755225,0275834,304

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonopoulou, S; Detopoulou, P; Fragopoulou, E; Nomikos, T; Panagiotakos, DB; Stamatakis, G1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cetylpyridinium chloride anhydrous

ArticleYear
PAF and its metabolic enzymes in healthy volunteers: interrelations and correlations with basic characteristics.
    Prostaglandins & other lipid mediators, 2012, Volume: 97, Issue:1-2

    Topics: Adult; Aging; Biocatalysis; Blood Glucose; Body Mass Index; Enzymes; Female; Health; Humans; Leukocytes; Lipid Metabolism; Male; Platelet Activating Factor; Sex Characteristics

2012